Cadila Pharmaceuticals Limited — Ethambutol Exporter Profile
Indian Pharmaceutical Exporter · #3 for Ethambutol · $1.7M export value · DGFT Verified
Cadila Pharmaceuticals Limited is the #3 Indian exporter of Ethambutol with $1.7M in export value and 34 verified shipments. Cadila Pharmaceuticals Limited holds a 0.1% market share in Ethambutol exports across 9 countries. The company exports 15 pharmaceutical products worth $20.2M across 11 therapeutic categories.
Cadila Pharmaceuticals Limited — Ethambutol Export Profile: Buyers & Destinations
Where Does Cadila Pharmaceuticals Limited Export Ethambutol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $764.0K | 23 | 76.1% |
| UNITED STATES | $50.0K | 1 | 5.0% |
| GERMANY | $50.0K | 1 | 5.0% |
| AUSTRALIA | $50.0K | 1 | 5.0% |
| BOLIVIA | $48.0K | 2 | 4.8% |
| UNITED KINGDOM | $21.3K | 2 | 2.1% |
| CUBA | $16.7K | 2 | 1.7% |
| JORDAN | $2.4K | 1 | 0.2% |
| TRINIDAD & TOBAGO | $1.5K | 1 | 0.2% |
Cadila Pharmaceuticals Limited exports Ethambutol to 9 countries. The largest destination is NETHERLANDS accounting for 76.1% of Cadila Pharmaceuticals Limited's Ethambutol shipments, followed by UNITED STATES (5.0%) and GERMANY (5.0%). These destinations reflect Cadila Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ethambutol from Cadila Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GDF TILBURG SRS D102TC | NETHERLANDS | $466.9K | 11 |
| THE MEDICAL EXPORT GROUP B.V. | NETHERLANDS | $259.7K | 9 |
| AUSTIN CHEMICAL COMPANY,INC | UNITED STATES | $50.0K | 1 |
| ASPEN PHARMA PTY LIMITED | AUSTRALIA | $50.0K | 1 |
| THE MEDICAL EXPORT GROUP B | NETHERLANDS | $50.0K | 1 |
| MINISTERIO DE SALUD | BOLIVIA | $28.6K | 1 |
| GDF TILLBURG SRS | NETHERLANDS | $21.8K | 2 |
| KENT PHARMA UK LTD. | UNITED KINGDOM | $21.3K | 2 |
| MINISTERIO DE | BOLIVIA | $19.4K | 1 |
| MEDICUBA SA IMPORTADORA Y | CUBA | $16.7K | 2 |
Cadila Pharmaceuticals Limited supplies Ethambutol to 13 buyers globally. The largest buyer is GDF TILBURG SRS D102TC (NETHERLANDS), followed by THE MEDICAL EXPORT GROUP B.V. (NETHERLANDS) and AUSTIN CHEMICAL COMPANY,INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ethambutol Export Value and How Much Does Cadila Pharmaceuticals Limited Contribute?
India exported $50.7M worth of Ethambutol through 1,410 shipments from 97 suppliers to 133 countries, serving 458 buyers globally. Cadila Pharmaceuticals Limited contributes $1.7M to this total, accounting for 0.1% of India's Ethambutol exports. Cadila Pharmaceuticals Limited ships Ethambutol to 9 countries through 13 buyers.
What Is the Average Shipment Value for Cadila Pharmaceuticals Limited's Ethambutol Exports?
Cadila Pharmaceuticals Limited's average Ethambutol shipment value is $50.0K per consignment, based on 34 shipments totaling $1.7M. The largest destination is NETHERLANDS (76.1% of Cadila Pharmaceuticals Limited's Ethambutol exports).
How Does Cadila Pharmaceuticals Limited Compare to Other Indian Ethambutol Exporters?
Cadila Pharmaceuticals Limited ranks #3 among 97 Indian Ethambutol exporters with a 0.1% market share. The top 3 exporters are LUPIN LIMITED ($15.8M), MACLEODS PHARMACEUTICALS LTD ($13.3M), MACLEODS PHARMACEUTICALS LIMITED ($6.5M). Cadila Pharmaceuticals Limited processed 34 shipments to 9 destination countries.
What Ethambutol Formulations Does Cadila Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHA DRG & MED ETHAMBUTOL 400MG TABLET CO | $307.5K | 7 |
| PHA DRG MED ETHAMBUTOL 400MG TABLET CONT ETHAMBUTOL HCL B P QTY 672T PAC | $75.5K | 2 |
| PHARMA MEDIC:ETHAMBUTOL HYDROCHLORIDE TA | $50.0K | 1 |
| ETHAMBUTOL 400MG TABLET R/M : ETHAMBUTO | $50.0K | 1 |
| MYAMBUTOL 400MG TABLET RAW MATERIAL:ETHAMBUTOL HCL 400MG BPBATCH B245E3005 MANUFACTURING DT-SEP-2023 EXP DT-AUG-2026 | $50.0K | 1 |
| ETHAMBUTOL 400MG TABLET ETHAMBUTOL HCL B.P. OTHER DTLS AS PER DOCUMENT | $50.0K | 1 |
| ETHAMBUTOL 400MG TABLET ETHAMBUTOL HCL B.P. OTHER DTLS AS PER INVOICE | $50.0K | 1 |
| PHARMACEUTICALS MEDICINES :ETHAMBUTOL 400MG TABLET ETHAMBUTOL HCL B.P. (24 X 28T) (2840 PACK) | $50.0K | 1 |
| ETHAMBUTOL 400MG TABLET ETHAMBUTOL HCL B.P BATCH ET075E4003,ET075E4005 MFG D-JUN-2024 EXP D-MAY-28 PACK-24X28T | $50.0K | 1 |
| ETHAMBUTOL 400MG TABLET ETHAMBUTOL HCL B.P. AS PER INVOICENOS | $37.1K | 4 |
Cadila Pharmaceuticals Limited exports 21 distinct Ethambutol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHA DRG & MED ETHAMBUTOL 400MG TABLET CO with 7 shipments worth $307.5K.
Regulatory Requirements: Exporting Ethambutol to Key Markets
What Cadila Pharmaceuticals Limited must comply with to export Ethambutol to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cadila Pharmaceuticals Limited Compare to Nearest Ethambutol Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MANEESH PHARMACEUTICALS LIMITED | $4.6M | 92 | 36 | $50.0K |
| 7 | SVIZERA LABS PRIVATE LIMITED | $2.3M | 46 | 14 | $50.0K |
| 3 | CADILA PHARMACEUTICALS LIMITED ★ | $1.7M | 34 | 9 | $50.0K |
| 8 | MANEESH PHARMACEUTICALS LTD | $400.0K | 8 | 5 | $50.0K |
| 9 | UNILINK PHARMA PRIVATE LIMITED | $291.9K | 6 | 2 | $48.7K |
Cadila Pharmaceuticals Limited ranks #3 among 97 Indian Ethambutol exporters. Average shipment value of $50.0K compared to the market average of $522.7K. The closest competitors by value are MANEESH PHARMACEUTICALS LIMITED and SVIZERA LABS PRIVATE LIMITED.
Which Indian Ports Ship Ethambutol Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 305 | 21.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 246 | 17.4% |
| DELHI AIR CARGO ACC (INDEL4) | 121 | 8.6% |
| DELHI AIR | 113 | 8.0% |
| NHAVA SHEVA SEA (INNSA1) | 94 | 6.7% |
| Bombay Air | 80 | 5.7% |
| JNPT | 67 | 4.8% |
| JNPT/ NHAVA SHEVA SEA | 63 | 4.5% |
What Other Tuberculosis Medications Products Does Cadila Pharmaceuticals Limited Export?
Cadila Pharmaceuticals Limited also exports these tuberculosis medications products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Cadila Pharmaceuticals Limited's Ethambutol Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Cadila Pharmaceuticals. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, causing major carriers to suspend or reroute transits. This has resulted in extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes, impacting the timely delivery of pharmaceuticals. (livemint.com)
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. However, the U.S. has also implemented tariffs on Active Pharmaceutical Ingredients (APIs), leading to a reshoring of manufacturing and affecting Indian firms. In response, some Indian companies have invested in U.S. facilities to circumvent these tariffs. (odrindia.in)
In the European Union, compliance with the Falsified Medicines Directive (FMD) has become imperative. Indian exporters must ensure stringent adherence to these regulations to maintain market access, necessitating investments in serialization and traceability systems.
Cadila Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is crucial for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) has previously issued warnings to Cadila Pharmaceuticals regarding deviations from standard manufacturing practices. (business-standard.com) To address such concerns, the company has invested in enhancing its quality control systems and manufacturing processes. Additionally, Cadila has engaged in legal proceedings concerning biosimilar approvals, highlighting the complexities of regulatory compliance in the biosimilars market. (legaleraonline.com)
About Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited exports 15 products worth $20.2M. Beyond Ethambutol, top products include Mebendazole, Verapamil, Folic, Domperidone, Fexofenadine. View the complete Cadila Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ethambutol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ethambutol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cadila Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 34 individual customs records matching Cadila Pharmaceuticals Limited exporting Ethambutol, covering 21 formulations to 9 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 133+ countries, 458+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ethambutol Export Data from Cadila Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cadila Pharmaceuticals Limited's Ethambutol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cadila Pharmaceuticals Limited
Full Company Profile →
15 products · $20.2M total trade · 11 categories
Ethambutol Stats
Company Overview
Top Products by Cadila Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cadila Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ethambutol. For current shipment-level data, contact TransData Nexus.